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Background
Altered cGMP signaling has been implicated in myocar-
dial depression, morbidity, and mortality associated with
sepsis. Previous studies, using inhibitors of soluble guan-
ylate cyclase (sGC), suggested that cGMP generated by
sGC contributed to the cardiac dysfunction and mortality
associated with sepsis. We used mice deficient in sGCα1
(sGCα1
-/-mice) to unequivocally determine the role of
sGCα1β1 in the development of cardiac dysfunction and
death associated with two models of inflammatory shock:
endotoxin-induced and TNF-induced shock.
Results
At baseline, echocardiographic assessment and invasive
hemodynamic measurements of left ventricular (LV)
dimensions and function did not differ between WT and
sGCα1
-/-mice on the C57BL/6 background (sGCα1
-/-B6
mice). Fourteen hours after a challenge with endotoxin,
cardiac dysfunction was more pronounced in sGCα1
-/-B6
mice than in WT mice, as assessed using echocardio-
graphic and hemodynamic indices of LV function. Simi-
larly, Ca2+ handling and cell shortening were impaired to
a greater extent in cardiac myocytes isolated from sGCα1
-/
-B6 mice than in those from WT mice after a challenge with
endotoxin. Importantly, morbidity and mortality associ-
ated with inflammatory shock induced either by endo-
toxin or TNF were increased in sGCα1
-/-B6  mice as
compared to WT mice.
Conclusion
Together, these findings suggest that cGMP generated by
sGCα1β1 protects against cardiac dysfunction and mortal-
ity in murine models of inflammatory shock.
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